Imaging challenges of immunotherapy and ...
Document type :
Article dans une revue scientifique: Article original
DOI :
PMID :
Permalink :
Title :
Imaging challenges of immunotherapy and targeted therapy in patients with brain metastases: response, progression, and pseudoprogression
Author(s) :
Galldiks, Norbert [Auteur]
Kocher, Martin [Auteur]
Ceccon, Garry [Auteur]
Werner, Jan-Michael [Auteur]
Brunn, Anna [Auteur]
Deckert, Martina [Auteur]
Pope, Whitney B. [Auteur]
Soffietti, Riccardo [Auteur]
Le Rhun, Emilie [Auteur]
Weller, Michael [Auteur]
Tonn, Jorg C. [Auteur]
Fink, Gereon R. [Auteur]
Langen, Karl-Josef [Auteur]
Kocher, Martin [Auteur]
Ceccon, Garry [Auteur]
Werner, Jan-Michael [Auteur]
Brunn, Anna [Auteur]
Deckert, Martina [Auteur]
Pope, Whitney B. [Auteur]
Soffietti, Riccardo [Auteur]
Le Rhun, Emilie [Auteur]
Weller, Michael [Auteur]
Tonn, Jorg C. [Auteur]
Fink, Gereon R. [Auteur]
Langen, Karl-Josef [Auteur]
Journal title :
Neuro-Oncology
Abbreviated title :
Neuro-oncology
Publication date :
2019-08-22
ISSN :
1523-5866
Keyword(s) :
radiomics
melanoma
lung cancer
immune checkpoint inhibitors
FET PET
brain metastasis
melanoma
lung cancer
immune checkpoint inhibitors
FET PET
brain metastasis
HAL domain(s) :
Sciences du Vivant [q-bio]
English abstract : [en]
The advent of immunotherapy using immune checkpoint inhibitors (ICIs) and targeted therapy (TT) has dramatically improved the prognosis of various cancer types. However, following ICI therapy or TT-either alone (especially ...
Show more >The advent of immunotherapy using immune checkpoint inhibitors (ICIs) and targeted therapy (TT) has dramatically improved the prognosis of various cancer types. However, following ICI therapy or TT-either alone (especially ICI) or in combination with radiotherapy-imaging findings on anatomical contrast-enhanced MRI can be unpredictable and highly variable, and are often difficult to interpret regarding treatment response and outcome. This review aims at summarizing the imaging challenges related to TT and ICI monotherapy as well as combined with radiotherapy in patients with brain metastases, and to give an overview on advanced imaging techniques which potentially overcome some of these imaging challenges. Currently, major evidence suggests that imaging parameters especially derived from amino acid PET, perfusion-/diffusion-weighted MRI, or MR spectroscopy may provide valuable additional information for the differentiation of treatment-induced changes from brain metastases recurrence and the evaluation of treatment response.Show less >
Show more >The advent of immunotherapy using immune checkpoint inhibitors (ICIs) and targeted therapy (TT) has dramatically improved the prognosis of various cancer types. However, following ICI therapy or TT-either alone (especially ICI) or in combination with radiotherapy-imaging findings on anatomical contrast-enhanced MRI can be unpredictable and highly variable, and are often difficult to interpret regarding treatment response and outcome. This review aims at summarizing the imaging challenges related to TT and ICI monotherapy as well as combined with radiotherapy in patients with brain metastases, and to give an overview on advanced imaging techniques which potentially overcome some of these imaging challenges. Currently, major evidence suggests that imaging parameters especially derived from amino acid PET, perfusion-/diffusion-weighted MRI, or MR spectroscopy may provide valuable additional information for the differentiation of treatment-induced changes from brain metastases recurrence and the evaluation of treatment response.Show less >
Language :
Anglais
Audience :
Internationale
Popular science :
Non
Administrative institution(s) :
INSERM
Université de Lille
Université de Lille
Collections :
Submission date :
2022-06-15T13:59:26Z